ETSTOTCPharmaceutical PreparationsFiscal year ends March 31

Earth Science Tech, Inc.

Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026

$0.09+0.00 (+3.73%)

Close on Oct 19, 2026

Market cap: $25.57M
P/E (TTM): 9.8
Dividend yield: –

Earth Science Tech, Inc. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2026 2026-03-31	FY 2025 2025-03-31	FY 2024 2024-03-31	FY 2023 2023-03-31	FY 2022 2022-03-31	FY 2021 2021-03-31	FY 2020 2020-03-31	FY 2019 2019-03-31	FY 2018 2018-03-31	FY 2015 2015-03-31	FY 2014 2014-03-31	FY 2013 2013-03-31	FY 2012 2012-03-31
Revenue	36	33	12	0.05	0.01	0.14	0.53	0.77	0.46	0.08	0.01	0.04	0.02
Cost of Revenue	10	8.82	4.13	0.03	0.02	0.10	0.31	0.48	0.27	0.08	0.00	0.01	0.00
Gross Profit	25	24	7.83	0.02	-0.01	0.04	0.22	0.30	0.19	0.00	0.01	0.04	0.02
Research & Development	–	–	–	0	0	0.01	0.08	0.34	0.15	0.03	–	–	–
Selling, General & Admin	3.57	4.15	0.17	0.23	0.12	–	–	–	–	–	–	–	–
Selling & Marketing	–	–	–	0.01	0.00	–	–	–	–	–	–	–	–
General & Administrative	–	–	–	0.23	0.12	0.23	0.55	0.51	0.65	0.12	0.01	–	–
Advertising Expenses	2.84	0.84	0.03	–	–	–	0.05	0.24	0.33	0.67	–	0.01	0
Operating Expenses	22	21	6.94	0.96	0.22	4.34	1.13	2.43	1.90	8.77	13	0.10	0.04
Operating Income	–	–	0.89	-0.94	-0.23	-4.30	-0.91	-2.14	-1.71	-8.77	-13	-0.06	-0.02
Interest Expense	0.02	0.02	0.00	0.05	0.09	0.00	0.00	0.08	0.00	0.00	–	–	–
Interest & Investment Income	–	0.00	–	–	–	–	–	–	–	–	–	–	–
Other Non-Operating Income	0.07	–	-0.07	0.57	3.40	-0.08	-0.29	-0.08	0.00	–	–	–	–
Asset Impairment Charges	–	–	–	–	–	–	–	0.03	–	–	–	–	–
Gain (Loss) on Sale of Assets	–	–	–	–	–	–	–	–	-0.06	–	–	–	–
Legal Settlements	–	–	–	–	–	-3.76	–	–	–	–	–	–	–
Pretax Income	3.09	3.37	0.83	-0.37	3.17	-4.38	-1.20	-2.22	-1.71	-8.77	-13	–	–
Income Tax Expense	-0.51	0.12	0.01	–	–	–	–	–	–	–	–	0	0
Net Income incl. Noncontrolling Interests	3.60	3.25	–	–	–	-4.38	-1.20	–	–	–	–	–	–
Minority Interest in Earnings	-0.03	–	–	–	–	–	–	–	–	–	–	–	–
Net Income	3.63	3.25	0.81	-0.37	3.17	-4.38	-1.20	-2.22	-1.71	-8.77	-13	-0.06	-0.02
EPS (Basic)(per share)	0.01	0.01	0.0030	-0.0030	0.06	-0.08	-0.03	-0.04	-0.04	-0.23	-1.17	-0.01	0.00
EPS (Diluted)(per share)	0.01	0.01	0.0030	-0.0030	–	-0.08	-0.03	-0.04	-0.04	-0.23	-1.17	-0.01	0.00
Shares Outstanding (Basic, Weighted)(shares)	293	304	310	146	54	–	–	–	–	37	11	9.49	6.70
Shares Outstanding (Diluted, Weighted)(shares)	293	304	310	146	54	–	–	–	–	37	11	9.49	6.70
EBITDA	–	–	1.04	-0.92	–	-4.30	-0.90	-2.13	-1.69	-8.76	–	–	–
Net Interest Income	–	-0.02	-0.07	-0.05	–	–	–	–	–	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 71.4%
Operating margin: –
Net margin: 10.8%
Return on equity, FY2026: 66.9%

Financial strength

Current ratio: 1.77
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 22.0%

Valuation

P/E ratio: 9.8
Price to sales: 0.71
Price to book: 3.48
Dividend yield: –